Principal Financial Group
RXST icon

Principal Financial Group’s RxSight RXST Stock Holding History

Principal Financial Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,486
Closed -$1.02M – 2302
2025
Q1 		$1.02M Buy
40,486
+561
+1% +$16.7K ﹤0.01% 1851
2024
Q4 		$1.37M Buy
39,925
+3,879
+11% +$175K ﹤0.01% 1841
2024
Q3 		$1.78M Buy
36,046
+240
+0.7% +$12.3K ﹤0.01% 1782
2024
Q2 		$2.15M Buy
35,806
+878
+3% +$50.2K ﹤0.01% 1753
2024
Q1 		$1.8M Buy
34,928
+26,164
+299% +$1.28M ﹤0.01% 1793
2023
Q4 		$353K Buy
8,764
+100
+1% +$2.93K ﹤0.01% 2024
2023
Q3 		$242K Sell
8,664
-215
-2% -$6.41K ﹤0.01% 2116
2023
Q2 		$256K Buy
+8,879
New +$198K ﹤0.01% 2120

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Principal Financial Group's RXST Position: Q2 2025 in Review

Principal Financial Group sold out of RxSight (RXST) in Q2 2025, closing a stake of 40,486 shares — an estimated $1.02M sold.

Principal Financial Group first reported a position in RXST in Q2 2023 and held it in 8 quarters. The position peaked at $2.15M in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • Principal Financial Group reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • Principal Financial Group sold 40,486 RxSight shares in Q2 2025, an estimated $1.02M.
  • Principal Financial Group first reported a position in RxSight in Q2 2023 and held it in 8 quarters.
  • Principal Financial Group's RxSight position peaked at $2.15M in Q2 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Principal Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.